The Brewers talking to Prince Fielder already

0 Comments

UPDATE: Tom Haudricort confirms that the Brewers met with Boras yesterday to talk about a Fielder extension. No offer was made, but the fact that they’re even talking now is unusual for a high-profile Boras client.

5:15 P.M.: Brewers’ beat writer Adam McCalvy noted some strange behavior by the Milwaukee brass (Milwaukee brass?) today:

Brewers general manager Doug Melvin and assistant GM Gord Ash
returned to camp on Thursday after an absence all day Wednesday. Asked
specifically whether it had anything to do with Fielder, Melvin said
only “we took a little trip.” Asked where that trip took him, Melvin said again: “We took a little trip.”

Ash wouldn’t dish, either, joking to a reporter that, “we don’t have to tell you guys everything.”

McCalvy speculates that they were off meeting Scott Boras at some undisclosed location to discuss Prince Fielder’s contract. I suppose that’s entirely possible. It’s also entirely possible that they all just “took a little trip” to the ladies room to powder their noses.

At least that’s the rumor I’m going to start spreading unless someone in the know gives me the dirt on what would be an unprecedentedly early contract negotiation for a Scott Boras client.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.